KIN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Stats
Today's Volume	178 496
Average Volume	1.51M
Market Cap	0.00
EPS	$-0.200 ( 2021-08-05 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.09
ATR14	$0.0820 (0.89%)

Insider Trading

Date	Person	Action	Amount	type
2021-08-27	Park West Asset Management Llc	Sell	6 000 002	Common Stock, par value $0.0001 per share
2021-08-27	Wee Wendy	Sell	78 613	Common Stock
2021-08-27	Wee Wendy	Sell	32 500	Stock Option (right to buy)
2021-08-27	Wee Wendy	Sell	10 000	Stock Option (right to buy)
2021-08-27	Wee Wendy	Sell	75 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 510 888 \| Sell: 9 693 361

Volume Correlation

Long: 0.19 (neutral)

Short: -0.40 (neutral)

Signal:(69.694) Neutral

Kindred Biosciences, Inc. Correlation

10 Most Positive Correlations
NVCN	0.974
FOCS	0.971
XM	0.963
CRVL	0.961
MLVF	0.961
ALGM	0.96
MDGL	0.96
ACLS	0.958
CTSO	0.957
ALGN	0.957

10 Most Negative Correlations
SNPX	-0.977
PDBC	-0.973
PIII	-0.973
UTME	-0.973
RIVN	-0.958
SMFL	-0.958
VORB	-0.957
NCBS	-0.946
TSHA	-0.945
SGLB	-0.943

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kindred Biosciences, Inc. Correlation - Currency/Commodity

-0.87
( strong negative )

-0.86
( strong negative )

0.76
( moderate )

-0.21
( neutral )

0.06
( neutral )

0.87
( strong )

Kindred Biosciences, Inc. Financials

Annual	2020
Revenue:	$42.16M
Gross Profit:	$37.54M (89.03 %)
EPS:	$-0.550

Q2	2021
Revenue:	$3.54M
Gross Profit:	$2.90M (81.93 %)
EPS:	$-0.200

Q1	2021
Revenue:	$2.40M
Gross Profit:	$1.81M (75.37 %)
EPS:	$-0.240

Q4	2020
Revenue:	$951 000
Gross Profit:	$570 000 (59.94 %)
EPS:	$-0.277

Financial Reports:

No articles found.

Kindred Biosciences, Inc.

Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.